CompuGroup Medical SE & Co. KGaA
CMPUY · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | 0.25 | -0.41 | -8.04 |
| FCF Yield | 6.90% | 0.87% | 2.47% | -1.64% |
| EV / EBITDA | 35.75 | 54.00 | 27.28 | 36.72 |
| Quality | ||||
| ROIC | 0.95% | -3.44% | 0.00% | 1.13% |
| Gross Margin | 84.49% | 82.41% | 84.02% | 24.09% |
| Cash Conversion Ratio | 8.50 | -4.08 | 3.60 | -0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.38% | 0.71% | 2.14% | 2.49% |
| Free Cash Flow Growth | 681.51% | -42.10% | 182.37% | -135.38% |
| Safety | ||||
| Net Debt / EBITDA | 13.73 | 21.66 | 14.36 | 13.89 |
| Interest Coverage | 2.59 | 12.79 | 0.00 | 3.15 |
| Efficiency | ||||
| Inventory Turnover | 2.95 | 3.69 | 2.43 | 11.74 |
| Cash Conversion Cycle | -68.62 | -71.52 | -50.29 | 44.82 |